TMS Co., Ltd. (TYO:4891)
143.00
-1.00 (-0.69%)
At close: Mar 6, 2026
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 6.5 billion as of March 6, 2026. Its market cap has decreased by -40.04% in one year.
Market Cap
6.50B
Enterprise Value
3.72B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
143.00
Market Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 6.50B, a decrease of -76.85%. That is a compound annual growth rate of -35.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.50B | 10.85% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSource | 7.57B |
| OncoTherapy Science | 7.53B |
| PRISM BioLab Co.,LTD | 7.46B |
| Chiome Bioscience | 7.22B |
| Linical | 7.11B |
| Carna Biosciences | 6.33B |
| Soiken Holdings | 6.15B |
| Noile-Immune Biotech | 6.11B |